Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
Jiaoyuan Jia(University of California, San Francisco), Xin Chen(University of California, San Francisco)
Cited by 42
Related Papers
Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver
|Oncotarget|2015|68
MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
|BMC Cancer|2019|52
Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway
|Experimental & Molecular Medicine|2018|50
Central role of mTORC1 downstream of YAP/TAZ in hepatoblastoma development
|Oncotarget|2017|36
Hippo Cascade Controls Lineage Commitment of Liver Tumors in Mice and Humans
|American Journal Of Pathology|2018|36